ALBERT CHA Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ALBERT CHA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ALBERT CHA. ALBERT CHA is Director in ProNAi Therapeutics Inc ($DNAI) and Director in Biodel Inc ($BIOD) and Director in Carbylan Therapeutics, Inc. ($CBYL) and Director in Aclaris Therapeutics, Inc. ($ACRS) and Director in Menlo Therapeutics, Inc. ($MNLO) and Director in Biohaven Pharmaceutical Holding Co Ltd. ($BHVN).
Latest Insider Trading Transactions of ALBERT CHA
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACRS, ALBO, BHVN, KALV, SRRA, MNLO
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Oct 02 2020 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Option Exercise | A | 12.88 | 7,000 | 90,160 | 7,000 | |
Oct 03 2019 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Option Exercise | A | 11.21 | 7,000 | 78,470 | 7,000 | |
Jul 30 2019 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Buy | P | 17.13 | 5,137 | 88,011 | 124,566 | 119.4 K to 124.6 K (+4.30 %) |
Jul 30 2019 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Buy | P | 17.13 | 24,730 | 423,692 | 1,022,493 | 997.8 K to 1 M (+2.48 %) |
Jul 30 2019 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Buy | P | 16.83 | 21,942 | 369,317 | 997,763 | 975.8 K to 997.8 K (+2.25 %) |
Jul 30 2019 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Buy | P | 16.83 | 4,558 | 76,718 | 119,429 | 114.9 K to 119.4 K (+3.97 %) |
Jul 19 2019 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Buy | P | 17.84 | 49,680 | 886,127 | 975,821 | 926.1 K to 975.8 K (+5.36 %) |
Jul 19 2019 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Buy | P | 17.68 | 10,320 | 182,453 | 114,871 | 104.6 K to 114.9 K (+9.87 %) |
Jul 19 2019 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Buy | P | 16.93 | 220 | 3,724 | 104,551 | 104.3 K to 104.6 K (+0.21 %) |
Jul 19 2019 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Buy | P | 16.97 | 1,060 | 17,991 | 926,141 | 925.1 K to 926.1 K (+0.11 %) |
Oct 05 2018 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Option Exercise | A | 22.65 | 7,000 | 158,550 | 7,000 | |
Sep 12 2018 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Buy | P | 17.00 | 1,058,824 | 18,000,008 | 1,359,149 | 300.3 K to 1.4 M (+352.56 %) |
Mar 15 2018 | BHVN | Biohaven Pharmaceu ... | Cha Albert | Director | Grant | A | 27.50 | 72,727 | 1,999,993 | 2,049,545 | 2 M to 2 M (+3.68 %) |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Option Exercise | C | 0.00 | 341,784 | 0 | 0 | |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Option Exercise | C | 0.00 | 2,475,118 | 0 | 0 | |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Option Exercise | C | 0.00 | 874,817 | 0 | 0 | |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Option Exercise | C | 0.00 | 6,335,215 | 0 | 0 | |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | C | 0.00 | 126,703 | 0 | 486,695 | 360 K to 486.7 K (+35.20 %) |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | C | 0.00 | 917,559 | 0 | 3,524,541 | 2.6 M to 3.5 M (+35.20 %) |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | C | 0.00 | 324,306 | 0 | 359,992 | 35.7 K to 360 K (+908.78 %) |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | C | 0.00 | 2,348,550 | 0 | 2,606,982 | 258.4 K to 2.6 M (+908.77 %) |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | P | 17.00 | 35,686 | 606,662 | 35,686 | 0 to 35.7 K |
Jan 29 2018 | MNLO | Menlo Therapeutics ... | Cha Albert | Director | Buy | P | 17.00 | 258,432 | 4,393,344 | 258,432 | 0 to 258.4 K |
Sep 29 2017 | KALV | KalVista Pharmaceu ... | Cha Albert | Director | Option Exercise | A | 6.71 | 6,000 | 40,260 | 6,000 | |
May 09 2017 | BHVN | Biohaven Pharmaceu ... | Cha Albert | Director | Option Exercise | C | 0.00 | 1,506,818 | 0 | 0 | |
May 09 2017 | BHVN | Biohaven Pharmaceu ... | Cha Albert | Director | Buy | P | 17.00 | 470,000 | 7,990,000 | 1,976,818 | 1.5 M to 2 M (+31.19 %) |
May 09 2017 | BHVN | Biohaven Pharmaceu ... | Cha Albert | Director | Buy | C | 0.00 | 1,506,818 | 0 | 1,506,818 | 0 to 1.5 M |
Mar 27 2017 | CBYL | KalVista Pharmaceu ... | Cha Albert | Director | Option Exercise | A | 7.88 | 12,000 | 94,560 | 12,000 | |
Jul 01 2016 | ACRS | Aclaris Therapeuti ... | CHA ALBERT | Director | Option Exercise | A | 18.32 | 6,632 | 121,498 | 6,632 | |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 1,375,405 | 0 | 0 | |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 1,818,182 | 0 | 0 | |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 8,652,500 | 0 | 0 | |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | CHA ALBERT | Director | Buy | P | 11.00 | 454,545 | 4,999,995 | 4,191,397 | 3.7 M to 4.2 M (+12.16 %) |
Oct 13 2015 | ACRS | Aclaris Therapeuti ... | CHA ALBERT | Director | Buy | C | 0.00 | 3,433,646 | 0 | 3,736,852 | 303.2 K to 3.7 M (+1,132.45 %) |
Oct 09 2015 | ACRS | Aclaris Therapeuti ... | CHA ALBERT | Director | Buy | P | 11.00 | 13,352 | 146,872 | 303,206 | 289.9 K to 303.2 K (+4.61 %) |
Jul 21 2015 | DNAI | ProNAi Therapeutic ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 44,991 | 0 | 0 | |
Jul 21 2015 | DNAI | ProNAi Therapeutic ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 2,064,308 | 0 | 0 | |
Jul 21 2015 | DNAI | ProNAi Therapeutic ... | CHA ALBERT | Director | Buy | P | 17.00 | 4,693 | 79,781 | 2,438,270 | 2.4 M to 2.4 M (+0.19 %) |
Jul 21 2015 | DNAI | ProNAi Therapeutic ... | CHA ALBERT | Director | Buy | P | 17.00 | 215,307 | 3,660,219 | 2,433,577 | 2.2 M to 2.4 M (+9.71 %) |
Jul 21 2015 | DNAI | ProNAi Therapeutic ... | CHA ALBERT | Director | Buy | J | 5.22 | 2,324 | 12,120 | 2,218,270 | 2.2 M to 2.2 M (+0.10 %) |
Jul 21 2015 | DNAI | ProNAi Therapeutic ... | CHA ALBERT | Director | Buy | J | 5.22 | 106,647 | 556,164 | 2,215,946 | 2.1 M to 2.2 M (+5.06 %) |
Jul 21 2015 | DNAI | ProNAi Therapeutic ... | CHA ALBERT | Director | Buy | C | 0.00 | 44,991 | 0 | 2,109,299 | 2.1 M to 2.1 M (+2.18 %) |
Jul 21 2015 | DNAI | ProNAi Therapeutic ... | CHA ALBERT | Director | Buy | C | 0.00 | 2,064,308 | 0 | 2,064,308 | 0 to 2.1 M |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 2,230 | 0 | 0 | |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 304,438 | 0 | 0 | |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 2,842 | 0 | 0 | |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 387,960 | 0 | 0 | |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 18,142 | 0 | 0 | |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Option Exercise | C | 0.00 | 2,476,452 | 0 | 0 | |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Buy | P | 5.00 | 7,364 | 36,820 | 4,204,564 | 4.2 M to 4.2 M (+0.18 %) |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Buy | P | 5.00 | 1,005,136 | 5,025,680 | 4,197,200 | 3.2 M to 4.2 M (+31.49 %) |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Buy | C | 0.00 | 2,230 | 0 | 3,192,064 | 3.2 M to 3.2 M (+0.07 %) |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Buy | C | 0.00 | 304,438 | 0 | 3,189,834 | 2.9 M to 3.2 M (+10.55 %) |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Buy | C | 0.00 | 2,842 | 0 | 2,885,396 | 2.9 M to 2.9 M (+0.10 %) |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Buy | C | 0.00 | 387,960 | 0 | 2,882,554 | 2.5 M to 2.9 M (+15.55 %) |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Buy | C | 0.00 | 18,142 | 0 | 2,494,594 | 2.5 M to 2.5 M (+0.73 %) |
Apr 14 2015 | CBYL | Carbylan Therapeut ... | CHA ALBERT | Director | Buy | C | 0.00 | 2,476,452 | 0 | 2,476,452 | 0 to 2.5 M |
May 18 2007 | BIOD | Biodel Inc | CHA ALBERT | Director | Option Exercise | C | 0.00 | 1,078,933 | 0 | 0 | |
May 18 2007 | BIOD | Biodel Inc | CHA ALBERT | Director | Buy | C | 0.00 | 1,078,933 | 0 | 1,685,632 | 606.7 K to 1.7 M (+177.84 %) |
Page: 1